Category Archives: Events

04Dec/18
veeva logo

Veeva is Building the Life Sciences Cloud with High Speed and Velocity

Veeva 2018 Summit Event Brief

By: Daniel R. Matlis, President

Introduction

“We are building the industry cloud for life sciences,” said Peter Gassner, president and CEO of Veeva during his keynote at the company’s summit in Philadelphia. “We want the industry and your company to be more efficient and effective – supporting your journey to improve and extend human life,” Gassner added.

The event brought together more than 1,400 life science professionals and experts showcasing the latest advancements for speeding product development in the industry.

Right Speed, Right Velocity

“Speed is one of Veeva’s core values,” said Gassner. I have a slightly different perspective.  I took Gassner aside and explained that Axendia’s analysis of the company shows that Veeva is operating at the right velocity – not simply at high speed.

veeva imageUnfortunately, our industry is ripe with examples where companies have adopted systems at breakneck speed – often to mitigate a regulatory finding, only to realize the application brought them in the wrong direction.  Testament to the ‘right speed, wrong velocity approach’ are the multitude of QMS point solutions that were implemented as a reaction to 483’s and warning letters.

Veeva has been moving with speed in the right direction; working closely with their industry customers to provide mature, preconfigured out-of-the-box suites of unified applications on a single cloud platform that support key areas across the entire product lifecycle.

Veeva has become a strategic technology partner to more than 675 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is focused on customer success through its commitment to innovation and product excellence.

My interactions with industry executives at the Summit confirm that Veeva is enabling life science companies to realize the benefits of a modern, cloud-based architecture and mobile applications for critical business functions – without compromising on industry-specific functionality or regulatory compliance.

To learn how Bristol-Myers Squibb, Gilead and Sysmex America are using Veeva’s cloud for life sciences.

Register to receive the full event brief.

 

22Sep/18
siemens-new-logo-600

Whether Identical or Fraternal, Digital Twins Offer Deep Product, Process and Performance Insights

Siemens Industry Analyst Conference 2018 Event Brief

By: Sandra K. Rodriguez, Market Analyst

The mercury was climbing outside of the Boston Marriott Long Wharf as Siemens executives took the stage to kick off Siemens’ 11th Annual Industry Analyst conference August 27-30, 2018.  “The boundaries between systems are disappearing,” said Tony Hemmelgarn, President and CEO at Siemens PLM Software.   Over the past eleven years, the company has invested $11B in mergers and acquisitions.  As a result, Siemens has optimized its integrated solutions portfolio for next generation product development, manufacturing and service.

siemens imageIn contrast to prior conferences, where the focus was on pulling the “Digital Thread” throughout the enterprise, the theme for this year’s event was ‘Innovation Without Boundaries.’  In support of the theme, multiple customers took the stage to demonstrate how their organizations were innovating without boundaries.      

Less than 2 hours into the conference, I was struck by the possibilities of Medical Device companies accessing and sharing product, process or performance data and having the ability to feedback information to the master digital twin in one platform.  The real power of a master digital twin lead me to think about the concept of ‘digital fraternal twins’ for not only closed-loop product lifecycle management but also change and configuration management in Med-Tech.    

Register to learn why I think the power of digital fraternal twins holds significant value for Life-Sciences companies. 

I also review how companies like Hackrod, Tronrud, Visteon, KUKA and W.L.Gore and others are leveraging the Siemens portfolio.  

02Aug/18
Outcome based Medicine-Low-Res

FDA: Simulation is Digital Evidence, Not Made Up Stuff

Digital Evidence is Already Being Used at FDA to Support Regulatory Submissions

By: Daniel R. Matlis, President

Tina Morrison PicFDA is leading the way in the use of simulation and modeling in the medical device industry. “Simulation is digital evidence, not made up stuff,” said Tina Morrison Ph.D., Deputy Director, Division of Applied Mechanics, OSEL, CDRH, U.S. FDA, during her keynote address on Day 2 of the Siemens PLM Industry event, hosted by Medtronic at their operational HQ in Minneapolis, MN.

For details on Day 1 of the event see At 21, Computer System Validation Comes of Age.

Day 2 also included presentations from Medtronic, Atrium Health, Siemens Healthineers, and Agilent Technologies on their use of simulation and modeling across the product lifecycle and the environment of care.

“Access to safe and effective medical device technology calls for Regulatory Grade computer models & simulations,” said Morrison.

“Many companies aim for the Digital Twin and end up getting a Digital Mutant” commented Brent Roberts, Vice President of Medical Supply Chain Strategy at WL Gore.  “I think one of the keys to ensuring you don’t end up with a digital mutant is to stick with partners who understand the journey and rely on them helping you translate your internal view to a rest of the world outlook,” Roberts added.

To receive a copy of this brief, please register here.

We also welcome you to Register for FDA Grand Rounds “Advancing Regulatory Science with Modeling and Simulation at FDA” on August 9, 2018 from 12 – 1pm EST.

30Jul/18
LiveWorx-18-logo-tagline

Partnering to do Well, Partnering to do Good

PTC LiveWorx 2018 Event Brief

By: Daniel R. Matlis, President

Partnership was the key theme at LiveWorx 2018. At the event, PTC showcased five major partnerships to highlight the need to embrace Digital Transformation as it navigates the ever-increasing rate of change:

  • ANSYS partnership to augment simulation and modeling
  • Microsoft partnership to augment mixed reality and cloud
  • Rockwell partnership to align smart factory
  • SYSMEX to support improved patient outcomes through IoMT
  • Boston Children’s Hospital to do good for children on the Autistic spectrum

Under the leadership of Jim Heppelmann, PTC President and CEO, the company is shifting its culture to be PTC = Prepared To Change.  Heppelmann described PTC’s own transformation, shifting from perpetual licensing to a subscription business model as well as moving its global headquarters from Needham to the Boston Seaport.

BostonChildren PicFor me, the highlight of the event was the collaboration between PTC and Boston Children’s Hospital on the use of augmented reality (AR) to help children with autism and related disorders communicate and learn more effectively.

Register to read more.

24Jul/18
Dassault LS Image

Dassault Targets Life-Sciences with Mind, Body and Soul

2018 Analyst Brief

By: Daniel R. Matlis, President 

At this year’s conference, Dassault Systèmes demonstrated that they are going after Life-Sciences with Mind, Body, and Soul. Under the leadership of Bernard Charlès, Vice Chairman, Chief Executive Officer, the company displays a rare culture focused on long term audacious goals, driven by unbridled passion yet measured by meticulous execution. Charlès has helped instill a culture of ongoing innovation to further consolidate Dassault Systèmes’ scientific capabilities and make science part of the company’s DNA.

According to Charlès, “Dassault is a company with a long term mentality focused on the success of its customers. Dassault is about creating differentiating software that meets the needs of its clients.

Jean Colombel, Vice-President, Life-Sciences at Dassault Systèmes, commented that the company is working to enable innovative patient experiences through an Holistic Patient-Centric strategy.

Daniel R. Matlis, President at Axendia

Daniel R. Matlis, President at Axendia

In this brief, we reveal how Dassault Systèmes is effectively:

  • Going After the Mind: Building on the success of the Living Heart project, Dassault decided to model another “simple” organ, the human brain, the home of the mind.
  • Improving the Body: The 3D Experience platform allows the design and testing of in-silico 3D experiments based on virtual models, informed by real world evidence.
  • Putting its Soul into Health: Digital environments are pushing the bounds of possibility to transform research, science, the pharmaceutical industry, and medicine in general.

Register to read the full event brief.